NCT06536491 - EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 19, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Diabetic Macular Edema

Interventions

DRUG

EC-104 high dose

Intravitreal injection

DRUG

EC-104 low dose

Intravitreal injection

DRUG

Dexamethasone intravitreal implant

Marketed product intravitreal injection

Trial Locations (1)

RECRUITING

Retina Associates of Florida, LLC, Tampa